RT @HeatherleeBail1: What are the outcomes of intensive SBP reduction in patients with ICH and excessively high initial systolic BP? @SCCMP…
RT @AshuPJadhav: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/b9yqIbCWBq via @JAMANeuro part of @JA…
RT @abbeyquest: @StrokeWVT
RT @JAMANeuro: Post hoc analysis of ATACH-II trial revealed higher rate of clinical deterioration and no benefit in hematoma expansion, mor…
RT @JAMANeuro: Post hoc analysis of ATACH-II trial revealed higher rate of clinical deterioration and no benefit in hematoma expansion, mor…
RT @tchaaban1: This always made sense and had supportive data before. It is NEVER a good idea to acutely drop the SBP from 240 to < 140 or…
RT @AshuPJadhav: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/b9yqIbCWBq via @JAMANeuro part of @JA…
RT @tchaaban1: This always made sense and had supportive data before. It is NEVER a good idea to acutely drop the SBP from 240 to < 140 or…
RT @AshuPJadhav: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/b9yqIbCWBq via @JAMANeuro part of @JA…
RT @SomaBanerjee73: This post hoc analysis urges caution with intensive blood pressure treatment in ICH patients with initial systolic bloo…
Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage - JAMA Neurology via BrainSights for iOS https://t.co/YnXJXvIPdK
Going back to the old <=25% reduction in BP rule of thumb - can treat ICH like hypertensive emergency. Simple to remember and seems to be safer than overreaching for those with very high BP.
RT @JAMANeuro: Post hoc analysis of ATACH-II trial revealed higher rate of clinical deterioration and no benefit in hematoma expansion, mor…
Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/RlVvLnUAMN via @JAMANeuro part of @JAMANetwork
RT @SomaBanerjee73: This post hoc analysis urges caution with intensive blood pressure treatment in ICH patients with initial systolic bloo…
@StrokeWVT
RT @SomaBanerjee73: This post hoc analysis urges caution with intensive blood pressure treatment in ICH patients with initial systolic bloo…
RT @SomaBanerjee73: This post hoc analysis urges caution with intensive blood pressure treatment in ICH patients with initial systolic bloo…
This post hoc analysis urges caution with intensive blood pressure treatment in ICH patients with initial systolic blood pressure of 220 mm Hg or more
RT @UCLStrokeRes: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/su8oU1UXHw via @JAMANeuro part of @J…
RT @tchaaban1: This always made sense and had supportive data before. It is NEVER a good idea to acutely drop the SBP from 240 to < 140 or…
This always made sense and had supportive data before. It is NEVER a good idea to acutely drop the SBP from 240 to < 140 or 160. Hopefully this calms down <140 fanatics #neurocriticalcare #MedTwitter
RT @FormigaFrancesc: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/dHWzEU5PVI a través de @JAMANeuro…
RT @FormigaFrancesc: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/dHWzEU5PVI a través de @JAMANeuro…
RT @JAMANeuro: Post hoc analysis of ATACH-II trial revealed higher rate of clinical deterioration and no benefit in hematoma expansion, mor…
RT @UCLStrokeRes: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/su8oU1UXHw via @JAMANeuro part of @J…
RT @StrokeImperial: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/VDjAQNV3zb via @JAMANeuro
RT @DrFelipeSuarez: Análisis post hoc del ATACH-II ➡️ tto agresivo de PA en pacientes con PAS > 220 demostró tasas + altas de deterioro clí…
So, guidelines should be updated. "...showed higher rates of neurological deterioration and no evidence of reducing hematoma expansion at 24 hours or death or severe disability at 90 days in those who underwent intensive systolic blood pressure reduction"
RT @AshuPJadhav: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/b9yqIbCWBq via @JAMANeuro part of @JA…
RT @UCLStrokeRes: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/su8oU1UXHw via @JAMANeuro part of @J…
RT @JAMANeuro: Post hoc analysis of ATACH-II trial revealed higher rate of clinical deterioration and no benefit in hematoma expansion, mor…
RT @StrokeImperial: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/VDjAQNV3zb via @JAMANeuro
RT @StrokeImperial: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/VDjAQNV3zb via @JAMANeuro
RT @StrokeImperial: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/VDjAQNV3zb via @JAMANeuro
Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/VDjAQNV3zb via @JAMANeuro
RT @ICU2EEG: Last night in the unit, I was asked why not choose the typical blood pressure target of < SBP 160/140 for a patient who presen…
RT @JAMANeuro: Post hoc analysis of ATACH-II trial revealed higher rate of clinical deterioration and no benefit in hematoma expansion, mor…
Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/su8oU1UXHw via @JAMANeuro part of @JAMANetwork
RT @cynarmandmd: Don’t forget to check out our podcast author interview on this article!!! #hypertension #intracerebralhemorrhage
RT @JAMANeuro: Post hoc analysis of ATACH-II trial revealed higher rate of clinical deterioration and no benefit in hematoma expansion, mor…
RT @FormigaFrancesc: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/dHWzEU5PVI a través de @JAMANeuro…
RT @FormigaFrancesc: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/dHWzEU5PVI a través de @JAMANeuro…
Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/F989c0ZDXV
RT @FormigaFrancesc: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/dHWzEU5PVI a través de @JAMANeuro…
RT @FormigaFrancesc: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/dHWzEU5PVI a través de @JAMANeuro…
RT @FormigaFrancesc: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/dHWzEU5PVI a través de @JAMANeuro…
RT @ICU2EEG: Last night in the unit, I was asked why not choose the typical blood pressure target of < SBP 160/140 for a patient who presen…
Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/dHWzEU5PVI a través de @JAMANeuro part of @JAMANetwork
RT @neurointensivos: Outcomes of Intensive Systolic Blood Pressure Reduction in Patients With Intracerebral Hemorrhage and Excessively High…
RT @Office_j: 死亡・障害は1.02 [0.73-1.78]。 https://t.co/Dzept5Fn16 https://t.co/yFvbp7RPOi
RT @neurointensivos: Outcomes of Intensive Systolic Blood Pressure Reduction in Patients With Intracerebral Hemorrhage and Excessively High…
RT @neurointensivos: Outcomes of Intensive Systolic Blood Pressure Reduction in Patients With Intracerebral Hemorrhage and Excessively High…
RT @DrFelipeSuarez: Análisis post hoc del ATACH-II ➡️ tto agresivo de PA en pacientes con PAS > 220 demostró tasas + altas de deterioro clí…
RT @JAMANeuro: Post hoc analysis of ATACH-II trial revealed higher rate of clinical deterioration and no benefit in hematoma expansion, mor…
RT @ICU2EEG: Last night in the unit, I was asked why not choose the typical blood pressure target of < SBP 160/140 for a patient who presen…
RT @JAMANeuro: Post hoc analysis of ATACH-II trial revealed higher rate of clinical deterioration and no benefit in hematoma expansion, mor…
RT @vasisht: Makes perfect sense: don’t tank the BP for someone who spends a lifetime at a higher pressure #Neurocriticalcare @neurocritica…
Análisis post hoc del ATACH-II ➡️ tto agresivo de PA en pacientes con PAS > 220 demostró tasas + altas de deterioro clínico, morbilidad y mortalidad @interneurona @pablolavados @fgiloarrojo @maramd @focastilla @Marco_Mendo @lasneuro @barrosfelipe
RT @AshuPJadhav: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/b9yqIbCWBq via @JAMANeuro part of @JA…
Don’t forget to check out our podcast author interview on this article!!! #hypertension #intracerebralhemorrhage
RT @JAMANeuro: Post hoc analysis of ATACH-II trial revealed higher rate of clinical deterioration and no benefit in hematoma expansion, mor…
死亡・障害は1.02 [0.73-1.78]。 https://t.co/Dzept5Fn16 https://t.co/yFvbp7RPOi
RT @JAMANeuro: Post hoc analysis of ATACH-II trial revealed higher rate of clinical deterioration and no benefit in hematoma expansion, mor…
RT @JAMANeuro: Post hoc analysis of ATACH-II trial revealed higher rate of clinical deterioration and no benefit in hematoma expansion, mor…
RT @AshuPJadhav: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/b9yqIbCWBq via @JAMANeuro part of @JA…
RT @ICU2EEG: Last night in the unit, I was asked why not choose the typical blood pressure target of < SBP 160/140 for a patient who presen…
Outcomes of Intensive Systolic Blood Pressure Reduction in Patients With Intracerebral Hemorrhage and Excessively High Initial Systolic Blood Pressure: Post Hoc Analysis of a Randomized Clinical Trial | Cerebrovascular Disease | JAMA Neurology | JAMA Net h
RT @JAMANeuro: Post hoc analysis of ATACH-II trial revealed higher rate of clinical deterioration and no benefit in hematoma expansion, mor…
RT @JAMANeuro: Post hoc analysis of ATACH-II trial revealed higher rate of clinical deterioration and no benefit in hematoma expansion, mor…
Makes perfect sense: don’t tank the BP for someone who spends a lifetime at a higher pressure #Neurocriticalcare @neurocritical @StrokeAHA_ASA
RT @AshuPJadhav: Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage https://t.co/b9yqIbCWBq via @JAMANeuro part of @JA…
Amazing to see how much additional value can be generated with posthoc analyses of RCT data.
What are the outcomes of intensive SBP reduction in patients with ICH and excessively high initial systolic BP? @SCCMPresident @SCCM @neurocritical https://t.co/XahXJCb5yX with editorial comment @JAMANeuro https://t.co/2QZYJXabYo
Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage ....another example where less is more? https://t.co/lNnaYadX8I via @JAMANeuro part of @JAMANetwork
RT @JAMANeuro: Post hoc analysis of ATACH-II trial revealed higher rate of clinical deterioration and no benefit in hematoma expansion, mor…
RT @JAMANeuro: Post hoc analysis of ATACH-II trial revealed higher rate of clinical deterioration and no benefit in hematoma expansion, mor…
RT @JAMANeuro: Post hoc analysis of ATACH-II trial revealed higher rate of clinical deterioration and no benefit in hematoma expansion, mor…
Post hoc analysis of ATACH-II trial revealed higher rate of clinical deterioration and no benefit in hematoma expansion, morbidity and mortality in #intracerebralhemorrhage patients with initial sysBP >220mmHg who received aggressive BP reduction https: